| Kendrick Watkins, MD | |
|
1701 E Pflugerville Pkwy, Pflugerville, TX 78660-8990 | |
| (512) 259-6000 | |
| Not Available |
| Full Name | Kendrick Watkins |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 1701 E Pflugerville Pkwy, Pflugerville, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528409711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | R9316 (Texas) | Secondary |
| 208600000X | Surgery | MT204712 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | R9316 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Home Health Skilled Services | Austin, TX | Home health agency |
| Baylor Scott & White Medical Center - Round Rock | Round rock, TX | Hospital |
| Baylor Scott & White Medical Center Pflugerville | Pflugerville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
This laser is supposed to rejuvenate vaginal tissue. But scientists say it's no better than a placebo.
New research led by investigators at Beth Israel Deaconess Medical Center provides the first direct evidence linking traumatic brain injury to Alzheimer's disease and chronic traumatic encephalopathy (CTE) - and offers the potential for early intervention to prevent the development of these debilitating neurodegenerative diseases.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.
Researchers have identified four factors that are associated with survival time in patients who undergo metastasectomy for metastatic renal cell carcinoma.
› Verified 1 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
This laser is supposed to rejuvenate vaginal tissue. But scientists say it's no better than a placebo.
New research led by investigators at Beth Israel Deaconess Medical Center provides the first direct evidence linking traumatic brain injury to Alzheimer's disease and chronic traumatic encephalopathy (CTE) - and offers the potential for early intervention to prevent the development of these debilitating neurodegenerative diseases.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.
Researchers have identified four factors that are associated with survival time in patients who undergo metastasectomy for metastatic renal cell carcinoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendrick Watkins, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-2111 | Kendrick Watkins, MD 1701 E Pflugerville Pkwy, Pflugerville, TX 78660-8990 Ph: (512) 259-6000 |
News Archive
This laser is supposed to rejuvenate vaginal tissue. But scientists say it's no better than a placebo.
New research led by investigators at Beth Israel Deaconess Medical Center provides the first direct evidence linking traumatic brain injury to Alzheimer's disease and chronic traumatic encephalopathy (CTE) - and offers the potential for early intervention to prevent the development of these debilitating neurodegenerative diseases.
Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by Shire Development Inc. in connection with INTUNIVTM (guanfacine hydrochloride), 4 mg.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.
Researchers have identified four factors that are associated with survival time in patients who undergo metastasectomy for metastatic renal cell carcinoma.
› Verified 1 days ago
Vikash Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E Pflugerville Pkwy, Pflugerville, TX 78660 Phone: 512-259-6000 Fax: 512-260-6005 | |
Radha S Mahale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 E Pflugerville Pkwy, Pflugerville, TX 78660 Phone: 512-259-6000 | |
Dr. Travis Michael Averitt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Autumn Slate Dr Ste 150, Pflugerville, TX 78660 Phone: 737-220-7200 Fax: 512-406-7339 | |
Dr. Sangeetha Mariappan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Autumn Slate Dr Ste 150, Pflugerville, TX 78660 Phone: 737-220-7200 | |
Dr. Thomas E Martens, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 18817 Heatherwilde Blvd, Ste 150, Pflugerville, TX 78660 Phone: 512-523-4878 Fax: 512-870-9770 | |
John Reagan Boyd, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Heatherwilde Blvd, Pflugerville, TX 78660 Phone: 512-989-7400 Fax: 512-989-0753 | |
Juan Davila, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1821 Fm 685, Pflugerville, TX 78660 Phone: 512-988-5355 Fax: 512-323-0307 |